Imaging & Diagnostics

The transition from intensity-based to volume-based metabolic assessment represents a significant shift in how oncologists might predict early treatment failure. While traditional staging systems rely heavily on tumor size and lymph node status, they often overlook the metabolic intricacies that

Integrating AI technology into the existing teleradiology workflow allows Krsnaa to maximize the utilization of its capital assets without increasing fixed costs. This strategic partnership with Azmed reflects a broader movement within the healthcare sector to stabilize diagnostic accuracy while

The diagnosis of metastatic medullary thyroid carcinoma is frequently hindered by the high physiological background activity of liver tissue in standard 18F-DOPA scans. This specific challenge is particularly problematic for patients with medullary thyroid carcinoma (MTC), a rare neuroendocrine

Research indicates that the willingness of a radiographer to correct a senior colleague is a prerequisite for maintaining the accuracy and safety of diagnostic procedures. This observation, emphasized in a major 2026 study published in Frontiers in Health Services, highlights a paradigm shift in

To maintain patient confidentiality during remote reviews, healthcare facilities must implement rigorous access controls and comprehensive digital audit trails for every electronic record. The National Medical Commission (NMC) recently released a pivotal advisory that fundamentally shifts how

New research shows that the patient-level diagnostic accuracy for clear cell renal cell carcinoma reached ninety-eight percent when using CAIX-targeted molecular imaging. This finding represents a monumental shift in the diagnostic landscape of renal oncology, moving away from generalized metabolic